| CAS: | 58-39-9 | ||||||||||||||||||||||||||||||||
| 分子式: | C21H26ClN3OS | ||||||||||||||||||||||||||||||||
| 分子量: | 403.97 | ||||||||||||||||||||||||||||||||
| 中文名称: |
| ||||||||||||||||||||||||||||||||
| 英文名称: |
| ||||||||||||||||||||||||||||||||
| 性质描述: | 白色或类白色结晶性粉末。熔点94-100℃;沸点278-281℃(0.133kPa),214-218℃(0.02kPa)。极易溶于氯仿,溶于乙醇(153mg/ml)、丙酮(82mg/ml),几乎不溶于水。对光敏感,几乎无臭,味微苦。 | ||||||||||||||||||||||||||||||||
| 生产方法: | N-(2-羟乙基)哌嗪与1,3-溴氯丙烷缩合得到1-(3-氯丙基)-4-(2-羟乙基)哌嗪。然后,将其与2-氯吩噻嗪缩合,制得奋乃静粗品。用乙酸乙酯重结晶,即得成品。 | ||||||||||||||||||||||||||||||||
| 用途: | 该品作用与氯丙嗪相似,具有抗精神病、降低体温、止吐和镇静等作用。适用于各类型的精神分裂症,对幻觉、妄想、焦虑、紧张和激动症状有效。亦可用于恶心、呕吐、呃逆及由焦虑、激动引起的失眠等。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| P1970 | TCI | Perphenazine | >97.0%(T)(HPLC) | 1095元/5G; 3860元/25G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 207906 | J&K | Perphenazine | 99% | 212元/1G; 773元/5G; 2424元/25G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| C46849 | Alfa Aesar | Perphenazine | 1361元/1g; 2883元/5g; 8550元/25g; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息 分子式 分子量 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P6402 | Sigma-Aldrich | Perphenazine | 1119.63元/1 G; 1642.3元/5 G; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Perphenazine is an antipsychotic drug used in treating schizophrenia. It modulates antioxidant levels and helps in the management of oxidative injury in schizophrenia. However, it is less effective than the clozapine drug group in improving response to oxidative injury. 包装 1, 5 g in glass bottle 生化/生理作用 D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. 特点和优势 This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. 其他说明 Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. P6402.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P0550000 | Perphenazine | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0001045 | Perphenazine for system suitability | European Pharmacopoeia (EP) Reference Standard | 1259.15元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. 包装 Unit quantity: 5 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR3079 | Supelco | Perphenazine | pharmaceutical secondary standard, certified reference material | 3006.17元/500 mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 生化/生理作用 D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC7546 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BP422 | Perphenazine | British Pharmacopoeia (BP) Reference Standard | 1861.35元/100 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1511000 | USP | Perphenazine | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 生化/生理作用 D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 094523 | Fluorochem | 2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]-piperazin-1-yl]ethanol | 98% | 330元/1g; 836元/5g; 2596元/25g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||